Skip to main content

Table 3 Baseline pain sensitivity and the risk of future persistent analgesic use within the 4.5 years of follow-up (n = 9,657). Prospective analysis

From: Pain sensitivity and analgesic use among 10,486 adults: the Tromsø study

 

Crude

n = 9,657

Model A

n = 9,559

Model B

n = 9,548

HR

95% CI

HR

95% CI

HR

95% CI

Withdrew handa

1.22

1.06–1.40

1.13

0.97–1.30

1.09

0.94–1.26

Did not withdraw hand

1

Ref

1

Ref

1

Ref

  1. HR hazard ratio, CI confidence interval
  2. Model A: Adjusted for age, sex and education
  3. Model B: Same as A but including chronic pain
  4. Persistent analgesic use: Use of NSAIDs, paracetamol or opioids for ≥ 90 days and with a proportion-of-days-covered ≥ 40%. In the study period, the persistent treatment episodes consisted on average of 39.3% NSAID, 44.0% opioid and 16.7% paracetamol prescriptions
  5. aThis group withdrew their hand in the cold pressor test. The reference group consists of those who endured the entire test of 106 s. Those who withdrew their hand are assumed less cold pain tolerant, i.e., more pain sensitive